Type 2 Diabetes
Authors: Shen Tian, Juan Wu, Jia-shuo Liu, Bao-shan Zou, Ling-quan Kong
Journal: Annals of Internal Medicine (2020)

Letters19 May 2020Type 2 DiabetesShen Tian, MD, Juan Wu, MD, Jia-shuo Liu, MD, Bao-shan Zou, MD, and Ling-quan Kong, MD, PhDShen Tian, MDFirst Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.T., J.W., J.L., B.Z., L.K.), Juan Wu, MDFirst Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.T., J.W., J.L., B.Z., L.K.), Jia-shuo Liu, MDFirst Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.T., J.W., J.L., B.Z., L.K.), Bao-shan Zou, MDFirst Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.T., J.W., J.L., B.Z., L.K.), and Ling-quan Kong, MD, PhDFirst Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.T., J.W., J.L., B.Z., L.K.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L20-0011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Vijan's In the Clinic article (1) summarizes the evidence supporting diabetes prevention and treatment. However, it includes some misleading information about the diagnosis and prevention of type 2 diabetes.First, the criteria for diagnosis of diabetes are not consistent with the current 2019 American Diabetes Association (ADA) recommendations. In the Diagnosis and Evaluation section, Vijan states that "diabetes can be diagnosed in persons with classic symptoms and a nonfasting glucose level of 11.1 mmol/L (200 mg/dL) or higher." The 2019 ADA guideline (2) states that persons with classic symptoms and a random plasma glucose level (not a ...References1. Vijan S. In the clinic: type 2 diabetes. Ann Intern Med. 2019;171:ITC65-ITC80. [PMID: 31683294]. doi:10.7326/AITC201911050 LinkGoogle Scholar2. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42:S13-S28. [PMID: 30559228] CrossrefMedlineGoogle Scholar3. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate and Hyperglycaemia. Report of a WHO/IDF Consultation. World Health Organization; 2006. Google Scholar4. Li H, Tian S, Wu J, et al. Diagnostic criteria should be considered when reviewing the effect of diabetes prevention studies [Letter]. Diabetologia. 2019;62:2163-2165. [PMID: 31515592] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: First Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.T., J.W., J.L., B.Z., L.K.)* Drs. Tian, Wu, and Kong contributed equally to this work.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L20-0011. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDementia Esther S. Oh and Peter V. Rabins Type 2 Diabetes Sandeep Vijan Metrics 19 May 2020Volume 172, Issue 10Page: 704-705KeywordsBlood plasmaConflicts of interestDiabetes preventionDisclosureGlobal healthGlucoseGlucose intoleranceHemoglobinOral glucose tolerance testType 2 diabetes ePublished: 19 May 2020 Issue Published: 19 May 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...